Triple Versus Dual Therapy In Patients With COPD

Synopsis A recent clinical study shows that triple inhaled therapy has positive effects on lung function and COPD symptoms as compared with dual therapy. The present study aims to evaluate the effect of triple therapy as compared to dual therapy in patients with COPD. This week’s “ MED FACT ” discusses a clinical trial from The New England Journal of Medicine, “ Once-Daily Single-Inhaler Triple versus Dual Therapy in Patients with COPD ” . May, 2018. Authors : David A.

Lipson; Frank Barnhart; Noushin Brealey; et. al. Key Takeaways: Triple therapy with fluticasone furoate, umeclidinium, and vilanterol resulted in a lower rate of moderate or severe COPD exacerbations than dual therapy. Objective: To compare the effect of triple therapy versus dual therapy in patients with COPD. Study Type: Randomized, double-blind, parallel-group, phase 3, multicenter trial Participants: 10,355   What…